3 ASX Growth Companies With Insider Ownership Up To 22%

In This Article:

The Australian market is on the cusp of another record high, buoyed by strong performances in global indices and robust commodity prices, particularly in iron ore and precious metals. In this thriving environment, identifying growth companies with significant insider ownership can be a strategic move for investors looking to align with those who have a vested interest in their company's success.

Top 10 Growth Companies With High Insider Ownership In Australia

Name

Insider Ownership

Earnings Growth

Clinuvel Pharmaceuticals (ASX:CUV)

10.4%

27.4%

Catalyst Metals (ASX:CYL)

17%

54.5%

Genmin (ASX:GEN)

12%

117.7%

AVA Risk Group (ASX:AVA)

15.7%

118.8%

Pointerra (ASX:3DP)

18.7%

126.4%

Liontown Resources (ASX:LTR)

16.4%

69.4%

Hillgrove Resources (ASX:HGO)

10.4%

70.9%

Acrux (ASX:ACR)

17.4%

91.6%

Adveritas (ASX:AV1)

21.1%

144.2%

Plenti Group (ASX:PLT)

12.8%

106.4%

Click here to see the full list of 101 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.

Let's dive into some prime choices out of the screener.

Clinuvel Pharmaceuticals

Simply Wall St Growth Rating: ★★★★★★

Overview: Clinuvel Pharmaceuticals Limited is a biopharmaceutical company that develops and commercializes treatments for genetic, metabolic, systemic, and life-threatening disorders across Australia, Europe, the United States, Switzerland, and internationally with a market cap of A$715.98 million.

Operations: The company's revenue primarily comes from the biopharmaceutical sector, amounting to A$88.18 million.

Insider Ownership: 10.4%

Clinuvel Pharmaceuticals, a growth company with high insider ownership, has reported substantial revenue and earnings growth, with revenues reaching A$95.31 million and net income of A$35.64 million for FY2024. The company is actively seeking M&A opportunities and has recently appointed three new non-executive directors to its board. Clinuvel's earnings are forecast to grow at 27.42% per year, significantly outpacing the Australian market average of 12.2%.

ASX:CUV Earnings and Revenue Growth as at Sep 2024
ASX:CUV Earnings and Revenue Growth as at Sep 2024

Develop Global

Simply Wall St Growth Rating: ★★★★★☆

Overview: Develop Global Limited, with a market cap of A$590.94 million, engages in the exploration and development of mineral resource properties in Australia through its subsidiaries.

Operations: Revenue Segments (in millions of A$): Develop Global generates revenue primarily from its Mining Services segment, which accounts for A$109.75 million.